Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Eva M. van Soest"'
Autor:
Wilhelm Haverkamp, Annamaria Colao, Miriam C. J. M. Sturkenboom, Gianluca Trifirò, Ron M. C. Herings, Douglas Ross, Katia M.C. Verhamme, R Zanettini, M. Mostafa Mokhles, Eva M. van Soest, Giampiero Mazzaglia, Guy van Camp, Jeanne P. Dieleman, Cynthia de Luise, Guy Brusselle, R Schade
Publikováno v:
Drug Safety, 35(2), 159-171. Adis
Drug Safety, 35(2), 159-171. Adis International Ltd
Trifirò, G, Mokhles, M M, Dieleman, J P, Soest, E M, Verhamme, K, Mazzaglia, G, Herings, R, Luise, C, Ross, D, Brusselle, G, Colao, A, Haverkamp, W, chade, R, Van Camp, G, Zanettini, R & Sturkenboom, M C 2012, ' Risk of cardiac valve regurgitation with dopamine agonist use in parkinsons disease and hyperprolactinaemia : A multi-country, nested case-control study ', Drug Safety, vol. 35, no. 2, pp. 159-171 . https://doi.org/10.2165/11594940-000000000-00000
Drug Safety, 35(2), 159-171. Adis International Ltd
Trifirò, G, Mokhles, M M, Dieleman, J P, Soest, E M, Verhamme, K, Mazzaglia, G, Herings, R, Luise, C, Ross, D, Brusselle, G, Colao, A, Haverkamp, W, chade, R, Van Camp, G, Zanettini, R & Sturkenboom, M C 2012, ' Risk of cardiac valve regurgitation with dopamine agonist use in parkinsons disease and hyperprolactinaemia : A multi-country, nested case-control study ', Drug Safety, vol. 35, no. 2, pp. 159-171 . https://doi.org/10.2165/11594940-000000000-00000
Background: There is growing evidence that ergot dopamine agonists may induce cardiac valve regurgitation (CVR) in persons with Parkinson’s disease. It is unclear whether the CVR risk is increased with ergot-dopamine agonist use in persons with hyp
Autor:
Willem Haverkamp, Cynthia de Luise, Mendel D. Haag, Guy van Camp, Miriam C. J. M. Sturkenboom, Katia M.C. Verhamme, R Zanettini, Gianluca Trifirò, Giampiero Mazzaglia, Douglas Ross, Jeanne P. Dieleman, Guy Brusselle, Ron M. C. Herings, M. Mostafa Mokhles, R Schade, Eva M. van Soest, Annamaria Colao
Publikováno v:
Pharmacological Research, 65(3), 358-364. Academic Press
Mokhles, M M, Trifirò, G, Dieleman, J P, Haag, M D, Van Soest, E M, Verhamme, K M C, Mazzaglia, G, Herings, R, De Luise, C, Ross, D, Brusselle, G, Colao, A, Haverkamp, W, Schade, R, Van Camp, G, Zanettini, R & Sturkenboom, M C J M 2012, ' The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease ', Pharmacological Research, vol. 65, no. 3, pp. 358-364 . https://doi.org/10.1016/j.phrs.2011.11.009
Pharmacological Research, 65(3), 358-364. Academic Press Inc.
Mokhles, M M, Trifirò, G, Dieleman, J P, Haag, M D, Van Soest, E M, Verhamme, K M C, Mazzaglia, G, Herings, R, De Luise, C, Ross, D, Brusselle, G, Colao, A, Haverkamp, W, Schade, R, Van Camp, G, Zanettini, R & Sturkenboom, M C J M 2012, ' The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease ', Pharmacological Research, vol. 65, no. 3, pp. 358-364 . https://doi.org/10.1016/j.phrs.2011.11.009
Pharmacological Research, 65(3), 358-364. Academic Press Inc.
The aim of present study was to investigate the risk of heart failure associated with dopamine agonist use in patients with Parkinson's disease. The data sources of this study were four different population-based, healthcare databases in United Kingd
Autor:
Eva M. van Soest, Miriam C. J. M. Sturkenboom, Jeanne P. Dieleman, Katia M.C. Verhamme, Ann M. Vanrolleghem, Gaganpreet Kaur, Bruno H. Ch. Stricker
Publikováno v:
Journal of Clinical Periodontology. 37:625-630
Kaur G, Verhamme KMC, Dieleman JP, Vanrolleghem A, van Soest EM, Stricker BHCh, Sturkenboom MCJM. Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol 2010; 37: 625–630. doi: 10.1111/j.1600-051X.2010.01574.x. Ab
Publikováno v:
BMJ Case Reports, 2018:bcr-2017-223206. BMJ Publishing Group
A 66-year-old man with seronegative, erosive rheumatoid arthritis for 12 years presented with malaise, elevated alkaline phosphatase and gamma-glutamyl transferase, and leg oedema. He subsequently developed ascites. No liver pathology was found, but
Autor:
Eva M. van Soest, Rob J. Ouwendijk, Monique E. van Leerdam, Sanna A. Mulder, Leo G. M. van Rossum, Ernst J. Kuipers, Jeanne P. Dieleman
Publikováno v:
European Journal of Gastroenterology & Hepatology, 22, 4, pp. 437-43
European Journal of Gastroenterology & Hepatology, 22, 437-43
European Journal of Gastroenterology & Hepatology, 22(4), 437-443. Lippincott Williams & Wilkins
European Journal of Gastroenterology & Hepatology, 22, 437-43
European Journal of Gastroenterology & Hepatology, 22(4), 437-443. Lippincott Williams & Wilkins
Contains fulltext : 88612.pdf (Publisher’s version ) (Closed access) OBJECTIVES: To assess the prior exposure to colorectal examinations between colorectal cancer (CRC) patients and matched control participants to estimate the effect of these exami
Publikováno v:
Expert Opinion on Drug Safety, 7(2), 173-180. Taylor & Francis Ltd
The most important risk factor of oesophageal adenocarcinoma is gastro-oesophageal reflux disease. Gastro-oesophageal reflux disease is in itself a common disorder, giving bothersome symptoms. in daily clinical practice, anticholinergic drugs are bel
Autor:
Peter D. Siersema, Jeanne P. Dieleman, Eva M. van Soest, Leny Schoof, Miriam C. J. M. Sturkenboom, Ernst J. Kuipers
Publikováno v:
American Journal of Gastroenterology, 102(9), 1870-1877. Springer Nature
Objective Incompetence of the lower esophageal sphincter (LES) is a key factor in the pathogenesis of gastroesophageal reflux disease (GERD). Drugs with anticholinergic properties, such as tricyclic antidepressants (TCAs), may facilitate GERD by a re
Autor:
Miriam C. J. M. Sturkenboom, Eva M. van Soest, Giampiero Mazzaglia, Jay L. Goldstein, Vera E. Valkhoff, Gianluca Trifirò, Ernst J. Kuipers, Sonia Hernandez-Diaz, R Schade, Mariam Molokhia
Publikováno v:
Arthritis & Rheumatism, 64(8), 2792-2802. John Wiley & Sons Ltd.
Objective Guidelines recommend coprescription of gastroprotective agents (GPAs) in patients receiving cyclooxygenase 2 inhibitors (coxibs) who are at high risk of upper gastrointestinal (UGI) tract complications (i.e., patients with a previous compli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760063ac08018b3361150f488adb6549
http://hdl.handle.net/10281/223289
http://hdl.handle.net/10281/223289
Autor:
Martijn J, Schuemie, Emine, Sen, Geert W, 't Jong, Eva M, van Soest, Miriam C, Sturkenboom, Jan A, Kors
Publikováno v:
Pharmacoepidemiology and drug safety. 21(6)
Increasingly, patient information is stored in electronic medical records, which could be reused for research. Often these records comprise unstructured narrative data, which are cumbersome to analyze. The authors investigated whether text mining can
Autor:
Giampiero Mazzaglia, Miriam C. J. M. Sturkenboom, Gianluca Trifirò, Sonia Hernandez-Diaz, Vera E. Valkhoff, Jeanne P. Dieleman, Eva M. van Soest, Jay L. Goldstein, R Schade, Mariam Molokhia, Ernst J. Kuipers
Background: Little is known about the upper gastrointestinal (UGI) protective effect of gastroprotective agents (GPAs) in COX-2-specific inhibitors (coxib)-users. Objectives: To study the association between GPA adherence and UGI complications among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9bbeb2c154986dc6a1bff89ea2c762
http://hdl.handle.net/10281/226772
http://hdl.handle.net/10281/226772